The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis

Circulation. 2024 Apr 16;149(16):1315-1318. doi: 10.1161/CIRCULATIONAHA.123.066933. Epub 2024 Apr 15.
No abstract available

Keywords: anticoagulants; factor Xa; factor Xa inhibitors; gastrointestinal hemorrhage; hemostasis.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects
  • Factor Xa
  • Factor Xa Inhibitors* / adverse effects
  • Gastrointestinal Hemorrhage* / chemically induced
  • Gastrointestinal Hemorrhage* / drug therapy
  • Humans
  • Recombinant Proteins / adverse effects
  • Rivaroxaban

Substances

  • Factor Xa Inhibitors
  • PRT064445
  • Factor Xa
  • Recombinant Proteins
  • Anticoagulants
  • Rivaroxaban